04/03/2024
7:14 PM | Alleva Lawrence M (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:05 PM | Mersana Therapeutics (Filer)
| Form POS AM | |
02/28/2024
7:49 AM | Mersana Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2024
7:43 AM | Mersana Therapeutics (Filer)
| Form POSASR | |
02/28/2024
6:07 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:56 PM | Mersana Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
7:43 PM | Mersana Therapeutics (Subject)
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
|
02/14/2024
5:55 PM | Mersana Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
8:20 AM | Avoro Capital Advisors LLC (Filed by)
Mersana Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
6:22 AM | BALYASNY ASSET MANAGEMENT L.P. (Filed by)
Mersana Therapeutics (Subject)
| Form SC 13G | |
01/22/2024
12:36 PM | Mersana Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/17/2024
4:16 PM | Bala Mohan (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:18 PM | DeSchuytner Brian (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:18 PM | Carvajal Alejandra (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:19 PM | Huber Martin H. Jr. (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:19 PM | Lowinger Timothy B (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:20 PM | Mandelia Ashish (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:21 PM | Mersana Therapeutics (Issuer)
MISRA TUSHAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:21 PM | Mersana Therapeutics (Issuer)
Protopapas Anna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
8:12 PM | Mersana Therapeutics (Subject)
Protopapas Anna (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
8:13 PM | DeSchuytner Brian (Reporting)
Mersana Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
8:13 PM | Lowinger Timothy B (Reporting)
Mersana Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
8:14 PM | Bala Mohan (Reporting)
Mersana Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
3:42 PM | Mersana Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/05/2024
7:06 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:14 PM | Hege Kristen (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:15 PM | Alleva Lawrence M (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:42 AM | Mersana Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
6:18 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2023
7:12 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
3:26 PM | Mersana Therapeutics (Issuer)
MOTT DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
3:27 PM | Alleva Lawrence M (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
3:29 PM | Hege Kristen (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
3:30 PM | Dere Willard H (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
3:31 PM | Huber Martin H. Jr. (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
7:27 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
4:59 PM | Carvajal Alejandra (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
4:51 PM | DeSchuytner Brian (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
4:53 PM | Mersana Therapeutics (Issuer)
MISRA TUSHAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
4:55 PM | Mandelia Ashish (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
4:57 PM | Lowinger Timothy B (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
These AI trades triggered this morning (545% return) (Ad) If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy |
09/07/2023
4:46 PM | Bala Mohan (Reporting)
Mersana Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2023
6:08 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
7:53 AM | Mersana Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023
7:04 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
12:55 PM | EcoR1 Capital, LLC (Reporting)
Mersana Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/27/2023
4:11 PM | EcoR1 Capital, LLC (Filed by)
Mersana Therapeutics (Subject)
| Form SC 13G | |
07/27/2023
6:32 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2023
3:23 PM | Huber Martin H. Jr. (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
3:24 PM | Alleva Lawrence M (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
3:18 PM | Mersana Therapeutics (Issuer)
MOTT DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
6:38 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
3:15 PM | Mersana Therapeutics (Issuer)
MOTT DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:16 PM | Huber Martin H. Jr. (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:17 PM | Hege Kristen (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
3:19 PM | Diaz Allene M. (Reporting)
Mersana Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2023
7:55 AM | Mersana Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023
6:11 AM | Mersana Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2023
5:00 AM | Mersana Therapeutics (Filer)
| Form DEF 14A | |
04/28/2023
5:02 AM | Mersana Therapeutics (Filer)
| Form DEFA14A | |
04/28/2023
5:04 AM | Mersana Therapeutics (Filer)
| Form ARS | |
